About Novo Nordisk A/S
Novo Nordisk is a global healthcare company specializing in diabetes care, obesity management, hemophilia care, and growth hormone therapy.
Sector
Pharmaceutical
Headquarters
Bagsvaerd, Denmark
Founded
1923
Employees
64,000
In the News
All coverage →
Industry
Dixon Technologies Secures 220 Million USD Corporate Guarantee for Lenovo Ireland IT Hardware Manufacturing
Clinical Trials
The 2026 Obesity Power Rankings: Which Pharma Giants Can Break the Lilly-Novo Duopoly?
Pharmaceutical
The Weight-Loss Drug Boom: Novo Nordisk's €432 Million Athlone Expansion